Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27614238 | 0.92 | MEN1 (0.44) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL11432705 | 0.90 | MEN1 (0.46) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL27918078 | 0.86 | MEN1 (0.48) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1728132 | 0.86 | MEN1 (0.48) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1406753 | 0.85 | MEN1 (0.40) | MEN1KMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL17652959 | 0.84 | HMGCR (0.34) | TSHRALDH1A1LMNAKDM4ECYP2C19 | |
| SCHEMBL1818399 | 0.84 | MEN1 (0.47) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1201910 | 0.81 | MEN1 (0.43) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL1244565 | 0.79 | MEN1 (0.54) | MEN1KMT2ATSHRALDH1A1LMNA | |
| SCHEMBL28283401 | 0.78 | MEN1 (0.47) | MEN1KMT2ATSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3030565-B1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | GRUENENTHAL GMBH (DE) | 2017-07-19 | — | — | EP | disclosed |
| US-9688683-B2 | Substituted condensed pyrimidine compounds | Grünenthal GmbH (DE) | 2017-06-27 | — | — | US | disclosed |
| US-20160152624-A1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | Grünenthal GmbH (DE) | 2016-06-02 | — | — | US | disclosed |
| EP-0299205-B1 | SUSTAINED RELEASE MICROCAPSULES AND METHOD FOR THE PRODUCTION THEREOF | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0299205-A1 | Sustained release microcapsules and method for the production thereof | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4000327-A | BERRY FRUIT FOODSTUFFS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-12-28 | — | — | US | disclosed |
| US-3984579-A | Novel flavoring compositions and products containing isomer mixtures containing high proportions of 2-methyl-cis-3-pentenoic acid | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-10-05 | — | — | US | disclosed |
| US-3931306-A | Process for producing isomer mixtures containing high proportions of cis-2-methyl-3-pentenoic acid | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931293-A | Processes for producing cis alkyl-2-methyl-3-pentenoates and isomer mixtures containing high proportions of cis alkyl-2-methyl-3-pentenoates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152624-A1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | PDE4A, PDE4B, TYMP | MEN1 3884/4885KMT2A 3000/4885TSHR 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.